Biomarkers of HPV in Head and Neck Squamous Cell Carcinoma
Caihua Liang(Pfizer (United States)), Karl T. Kelsey(Brown University), E. Andrés Houseman(Oregon State University), Michael D. McClean(Boston University), Heather H. Nelson(University of Minnesota), Richard O. Wein(Tufts University), Gregory A. Grillone(Boston University), Jeffrey F. Krane(University of California, Los Angeles), Robert I. Haddad(Georgetown University), Tim Waterboer(German Cancer Research Center), Brock C. Christensen(Dartmouth College), Michael Pawlita(DKFZ-ZMBH Alliance), John R. Clark(University of Arkansas System), Gordana Halec(Tufts Medical Center), Carmen J. Marsit(Emory University)
Cited by 140
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Clinicopathological Evaluation of Chronic Traumatic Encephalopathy in Players of American Football
|JAMA|2017|1.1k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926